Down-regulation of mitogen-activated protein kinases and nuclear factor-κB signaling is involved in rapamycin suppression of TLR2-induced inflammatory response in monocytic THP-1 cells

Microbiology and Immunology
Ruili SunHui Wang

Abstract

Tripalmitoyl-S-glycero-Cys-(Lys) 4 (Pam3CSK4) interacted with TLR2 induces inflammatory responses through the mitogen-activated protein kinases (MAPKs) and nuclear factor-κB (NF-κB) signal pathway. Rapamycin can suppress TLR-induced inflammatory responses; however, the detailed molecular mechanism is not fully understood. Here, the mechanism by which rapamycin suppresses TLR2-induced inflammatory responses was investigated. It was found that Pam3CSK4-induced pro-inflammatory cytokines were significantly down-regulated at both the mRNA and protein levels in THP-1 cells pre-treated with various concentrations of rapamycin. Inhibition of phosphatidylinositol 3-kinase/protein kinase-B (PI3K/AKT) signaling did not suppress the expression of pro-inflammatory cytokines, indicating that the immunosuppression mediated by rapamycin in THP1 cells is independent of the PI3K/AKT pathway. RT-PCR showed that Erk and NF-κB signal pathways are related to the production of pro-inflammatory cytokines. Inhibition of Erk or NF-κB signaling significantly down-regulated production of pro-inflammatory cytokines. Additionally, western blot showed that pre-treatment of THP-1 cells with rapamycin down-regulates MAPKs and NF-κB signaling induced by Pam3CS...Continue Reading

References

May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A E MedvedevS N Vogel
Aug 3, 2002·Nature Immunology·Taro FukaoShigeo Koyasu
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Dec 24, 2002·Current Opinion in Immunology·Shizuo Akira
Jan 14, 2003·Annual Review of Immunology·Kiyoshi TakedaShizuo Akira
Nov 20, 2004·Nature Reviews. Neuroscience·Eric Klann, Thomas E Dever
Jun 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Cory M JohannessenKaren Cichowski
Jan 10, 2009·American Journal of Respiratory Cell and Molecular Biology·Emmanuel LorneEdward Abraham
Jan 16, 2009·Biochemical Society Transactions·Jingxiang Huang, Brendan D Manning
Jan 20, 2009·Journal of Child Neurology·Jennifer MuncyMary Kay Koenig
Jul 10, 2009·Nature·David E HarrisonRichard A Miller
Jul 15, 2009·Nature Reviews. Rheumatology·Roberto BaccalaArgyrios N Theofilopoulos
Dec 4, 2009·Oncogene·S Menon, B D Manning
Jan 1, 2009·Progress in Molecular Biology and Translational Science·Mauro Costa-MattioliJoel D Richter
Apr 30, 2010·Kidney International·Hans-Joachim Anders, Detlef O Schlondorff
Mar 18, 2011·The New England Journal of Medicine·Francis X McCormackUNKNOWN MILES Trial Group
Apr 14, 2011·Cancer Research·Jessica L Yecies, Brendan D Manning
Jul 21, 2011·Nature Reviews. Neuroscience·Jordi BovéMiquel Vila
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Dec 20, 2012·Nature Communications·Atsushi SatoMasashi Mizuguchi
Mar 5, 2013·The Journal of Clinical Investigation·Dudley W LammingJoseph A Baur
Apr 22, 2014·Molecular Cancer Therapeutics·Rodrigo DienstmannJosep Tabernero
Oct 14, 2014·Frontiers in Immunology·Takumi Kawasaki, Taro Kawai
Mar 5, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D Fantus, A W Thomson

❮ Previous
Next ❯

Citations

Dec 31, 2019·BioMed Research International·Chuanyun FuDongsheng Zhang
Mar 16, 2021·Environmental Toxicology·Ning LiYulan Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.